About the Journal
Scope and Editorial Line
The Papers of Medical Sciences (Pap. Med. Sci.) is the official bilingual and international journal of the Association for the Promotion of Health, Research and Education (APHRE). It publishes continuous, high-quality original research covering all fields of medicine, biology, and health sciences.
The journal accepts original articles, editorials, review articles, clinical cases, letters to the editor, conference proceedings, and practical guidelines.
Open Access Policy
This journal applies a full Gold Open Access policy. All articles are freely available immediately upon publication, without subscription or access fees.
The journal strongly supports the principle that the free dissemination of scientific knowledge promotes health equity and improves healthcare worldwide.
© Copyright and Licensing
Authors retain full copyright of their work. Articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license permits unrestricted use, distribution, and adaptation of the work, provided that proper credit is given to the original authors and source.
Peer Review Process
All submitted manuscripts, except editorials and letters to the editor, undergo a rigorous double-blind peer review process conducted by at least two independent experts.
The anonymity of both authors and reviewers is strictly maintained to ensure objectivity and scientific quality.
Privacy Statement
Names, affiliations, and email addresses entered on the journal website are used exclusively for editorial purposes (manuscript processing, communication, and publication alerts). They are neither shared with third parties nor used for commercial purposes.
Archiving Policy
The Papers of Medical Sciences uses the LOCKSS and CLOCKSS secure archiving systems integrated into OJS to ensure long-term preservation and permanent access to all published articles.
Sponsorship
The journal is fully funded by the Association for the Promotion of Health, Research and Education (APHRE). It receives no advertising revenue or pharmaceutical industry support, ensuring full editorial independence.
